Propose to your loved one this Valentine's Day with an onion ring at Red Robin and you might get a free diamond ring valued at up to $10,000, assuming your partner doesn't leave you over it.

The coach, Gary Scott Goins, was convicted of 17 sex-related crimes in 2014 and sentenced to at least 34 years in prison. The former student-athletes sued the Gaston County Board of Education and ...

Drew Goins, a writer for Washington Post Opinions from Honolulu, was recently on the Champions Wildcard tournament of "Jeopardy!" when he missed a clue about Celine Dion, who he thanked during his ...

The U.S. Food and Drug Administration (FDA) has officially approved Ozempic to help reduce the risk of serious kidney complications in people with Type 2 diabetes and chronic kidney disease. Type 2 ...

One “Jeopardy!” contestant had a bit of a blunder when it came to a Céline Dion hit. Drew Goins, a Hawaii-based journalist who was competing in the “Jeopardy!” 2025 Champions Wildcard ...

Not all chemical hair relaxers include the chemical, but many include ingredients that can release formaldehyde when heated, the FDA said in 2024. Over the years, an increasing number of studies ...

However, it had to be used in conjunction with an oral medication. The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

They'll move from Pig to Pig,” its founder Robin Hutson tells me. “They’re very keen to tell you how they've collected the set of Pigs, if you know what I mean. You know: ‘we've been to ...

Johnson & Johnson's Spravato has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral antidepressants, the FDA announced Tuesday.